CA Patent

CA3062005A1 — Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof

Assigned to NVN Liquidation Inc · Expires 2011-02-24 · 15y expired

What this patent protects

Provided according to some embodiments of the invention are topical gels that may release nitric oxide. Also provided are uses of using such topical gels in the treatment of wounds and other skin ailments. The topical gels comprise diazeniumdiolate functionalized polysiloxane mac…

USPTO Abstract

Provided according to some embodiments of the invention are topical gels that may release nitric oxide. Also provided are uses of using such topical gels in the treatment of wounds and other skin ailments. The topical gels comprise diazeniumdiolate functionalized polysiloxane macromolecules and a hydrophobic, non-aqueous gel base.

Drugs covered by this patent

Patent Metadata

Patent number
CA3062005A1
Jurisdiction
CA
Classification
Expires
2011-02-24
Drug substance claim
No
Drug product claim
No
Assignee
NVN Liquidation Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.